Menopause Hormone Therapy (HRT) in Santa Cruz, CA

Bioidentical hormones in Santa Cruz: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

Santa Cruz is a center for OB-GYN care: the federal NPI registry lists 35 OB-GYNs with a primary practice address in the city, 57.4 per 100,000 residents, 3.2 times the US rate of 17.8 and above California's 16.9. That is more per resident than 89% of the 924 cities VevaMD covers. Set against the city's 6,106 women aged 45 to 64, that is one OB-GYN for roughly every 170.

Within 10 miles of the city there are 40 OB-GYNs, and within 25 miles 252, about 23.1 per 100,000 of the 1,093,143 residents in that radius. Whether or not you have an OB-GYN, you can ask a physician licensed in California about menopause hormone therapy online from Santa Cruz, with no waiting room.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in California decides what, if anything, fits, and the form. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11